Structural characterisation and biological activities of a unique type β-D-glucan obtained from Aureobasidium pullulans

Glycoconjugate Journal

Volumn 25, Issue 9, 2008, Pages 851-861

  Tada, Rui ^a   Tanioka, Asuka ^b   Iwasawa, Haruyo ^c   Hatashima, Kumi ^b   Shoji, Yoshikazu ^b   Ishibashi, Ken Ichi ^a   Adachi, Yoshiyuki ^a   Yamazaki, Masatoshi ^c   Tsubaki, Kazufumi ^b   Ohno, Naohito ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

^b ADEKA CORPORATION   (Japan)

^c TEIKYO UNIVERSITY   (Japan)

Author keywords

D glucan; Aureobasidium pullulans; Biological activity; NMR; Structure

Indexed keywords

1,6 BETA GLUCOPYRANOSYL; BETA 1,3 GLUCAN; BETA GLUCAN; GLUCOSE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; AUREOBASIDIUM PULLULANS; BIOLOGICAL ACTIVITY; CARBOHYDRATE ANALYSIS; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG ISOLATION; DRUG STRUCTURE; ENTEROBACTERIACEAE; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; MALE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL;

ANIMALS; ASCOMYCOTA; BETA-GLUCANS; CARBOHYDRATE CONFORMATION; CARBOHYDRATE SEQUENCE; CELL COUNT; CYTOKINES; ENTEROCOCCUS FAECALIS; EXUDATES AND TRANSUDATES; HUMANS; INJECTIONS; LYMPHOCYTES; MACROPHAGES; MAGNETIC RESONANCE SPECTROSCOPY; MICE; MOLECULAR SEQUENCE DATA; PERITONEUM; SERUM; TIME FACTORS;

AUREOBASIDIUM PULLULANS; ENTEROBACTERIACEAE; FUNGI;

EID: 56949099339     PISSN: 02820080     EISSN: 15734986     Source Type: Journal    
DOI: 10.1007/s10719-008-9147-3     Document Type: Article

References (33)

1. T. Yadomae 2000 Structure and biological activities of fungal beta-1,3-glucans Yakugaku Zasshi 120 413 431
2. T. Yadomae N. Ohno 1996 Structure-activity relationship of immunomodulating (1®3)-beta-d-glucans Rec. Res. Dev. Chem. Pharm. Sci 1 23 33
3. Y.T. Kim E.H. Kim C. Cheong D.L. Williams C.W. Kim S.T. Lim 2000 Structural characterization of beta-D-(1 ® 3, 1 ® 6)-linked glucans using NMR spectroscopy Carbohydr. Res 328 331 341
4. A.T. Borchers C.L. Keen M.E. Gershwin 2004 Mushrooms, tumors, and immunity: an update Exp. Biol. Med. (Maywood) 229 393 406
5. K. Hamano H. Gohra T. Katoh Y. Fujimura N. Zempo K. Esato 1999 The preoperative administration of lentinan ameliorated the impairment of natural killer activity after cardiopulmonary bypass Int. J. Immunopharmacol. 21 531 540
6. S. Kalra S. Jood 2000 Effect of dietary barley beta-glucan on cholesterol and lipoprotein fractions in rats J. Cereal Sci. 31 141 145
7. T. Taguchi H. Furue T. Kimura T. Kondo T. Hattori N. Ogawa 1983 Clinical efficacy of lentinan on neoplastic diseases Adv. Exp. Med. Biol. 166 181 187
8. S. Fujimoto K. Orita T. Kimura T. Kondo T. Taguchi K. Yoshida N. Ogawa H. Furue 1983 Clinical evaluation of SPG (schizophyllan) as a therapeutic adjuvant after surgery of gastric cancer-controlled study by an envelope method Gan To Kagaku Ryoho 10 1135 1145
9. M.S. Deshpande V.B. Rale J.M. Lynch 1992 Aureobasidium pullulans in applied microbiology: a status report Enzyme Microb. Technol. 14 514 527
10. S. Yuen 1974 Pullulans and its applications Process Biochem. 9 7 9
11. Y. Kimura M. Sumiyoshi T. Suzuki M. Sakanaka 2006 Antitumor and antimetastatic activity of a novel water-soluble low molecular weight beta-1, 3-d-glucan (branch beta-1,6) isolated from Aureobasidium pullulans 1A1 strain black yeast Anticancer Res. 26 4131 4141
12. N. Ikewaki N. Fujii T. Onaka S. Ikewaki H. Inoko 2007 Immunological actions of Sophy beta-glucan (beta-1,3-1,6 glucan), currently available commercially as a health food supplement Microbiol. Immunol. 51 861 873
13. Y. Kimura M. Sumiyoshi T. Suzuki T. Suzuki M. Sakanaka 2007 Inhibitory effects of water-soluble low-molecular-weight beta-(1,3-1,6)-d-glucan purified from Aureobasidium pullulans GM-NH-1A1 strain on food allergic reactions in mice Int. Immunopharmacol. 7 963 972
14. H.D. Shin K.J. Yang B.R. Park C.W. Son H.J. Jang S.K. Ku 2007 Antiosteoporotic effect of Polycan, beta-glucan from Aureobasidium, in ovariectomized osteoporotic mice Nutrition 23 853 860
15. G.D. Ross J.A. Cain B.L. Myones S.L. Newman P.J. Lachmann 1987 Specificity of membrane complement receptor type three (CR3) for beta-glucans Complement 4 61 74
16. J.W. Zimmerman J. Lindermuth P.A. Fish G.P. Palace T.T. Stevenson D.E. DeMong 1998 A novel carbohydrate-glycosphingolipid interaction between a beta-(1-3)-glucan immunomodulator, PGG-glucan, and lactosylceramide of human leukocytes J. Biol. Chem. 273 22014 22020
17. G.D. Brown S. Gordon 2001 Immune recognition. A new receptor for beta-glucans Nature 413 36 37
18. S. Saijo N. Fujikado T. Furuta S.H. Chung H. Kotaki K. Seki K. Sudo S. Akira Y. Adachi N. Ohno T. Kinjo K. Nakamura K. Kawakami Y. Iwakura 2007 Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans Nat. Immunol. 8 39 46
19. Y. Adachi T. Ishii Y. Ikeda A. Hoshino H. Tamura J. Aketagawa S. Tanaka N. Ohno 2004 Characterization of beta-glucan recognition site on C-type lectin, dectin 1 Infect. Immun. 72 4159 4171
20. K. Ishibashi N.N. Miura Y. Adachi N. Ohno T. Yadomae 2001 Relationship between solubility of grifolan, a fungal 1,3-beta-D-glucan, and production of tumor necrosis factor by macrophages in vitro Biosci. Biotechnol. Biochem. 65 1993 2000
21. N. Ohno M. Uchiyama A. Tsuzuki K. Tokunaka N.N. Miura Y. Adachi M.W. Aizawa H. Tamura S. Tanaka T. Yadomae 1999 Solubilization of yeast cell-wall beta-(1®3)-d-glucan by sodium hypochlorite oxidation and dimethyl sulfoxide extraction Carbohydr. Res. 316 161 172
22. C. Griesinger G. Otting K. Wuthrich R.R. Ernst 1988 Clean TOCSY for proton spin system identification in macromolecules J. Am. Chem. Soc. 110 7870 7872
23. B.O. Petersen E. Vinogradov W. Kay P. Wurtz N.T. Nyberg J.O. Duus O.W. Sorensen 2006 H2BC: a new technique for NMR analysis of complex carbohydrates Carbohydr. Res. 341 550 556
24. N.T. Nyberg J.O. Duus O.W. Sorensen 2005 Editing of H2BC NMR spectra Magn. Reson. Chem. 43 971 974
25. N.T. Nyberg J.O. Duus O.W. Sorensen 2005 Heteronuclear two-bond correlation: suppressing heteronuclear three-bond or higher NMR correlations while enhancing two-bond correlations even for vanishing 2JCH J. Am. Chem. Soc. 127 6154 6155
26. K. Morikawa Y. Kikuchi M. Abe M. Yamazaki D. Mizuno 1984 Early cellular responses in the peritoneal cavity of mice to antitumor immunomodulators Gann 75 370 378
27. R. Tada N. Nagi-Miura Y. Adachi N. Ohno 2007 An unambiguous assignment and structural analysis using solution NMR experiments of O-antigen from Escherichia coli ATCC23505 (serotype O9) Chem. Pharm. Bull. 55 992 995
28. S. Masuzawa M. Yoshida K. Ishibashi N. Saito M. Akashi N. Yoshikawa T. Suzuki S. Nameda N. Nagi-Miura Y. Adachi N. Ohno 2003 Solubilized Candida cell wall β-glucan, CSBG, is an epitope of natural human antibody Drug Dev. Res. 58 179 189
29. T. Harada N. Nagi-Miura Y. Adachi M. Nakajima T. Yadomae N. Ohno 2003 Antibody to soluble 1,3/1,6-beta-d-glucan, SCG in sera of naïve DBA/2 mice Biol. Pharm. Bull. 26 1225 1228
30. K. Ishibashi M. Yoshida I. Nakabayashi H. Shinohara N.N. Miura Y. Adachi N. Ohno 2005 Role of anti-beta-glucan antibody in host defense against fungi FEMS Immunol. Med. Microbiol. 44 99 109
31. Y. Kimura M. Sumiyoshi T. Suzuki M. Sakanaka 2007 Effects of water-soluble low-molecular-weight beta-1, 3-D-glucan (branch beta-1, 6) isolated from Aureobasidium pullulans 1A1 strain black yeast on restraint stress in mice J. Pharm. Pharmacol. 59 1137 1144
32. N. Ohno I. Suzuki T. Yadomae 1986 Structure and antitumor activity of a beta-1,3-glucan isolated from the culture filtrate of Sclerotinia sclerotiorum IFO 9395 Chem. Pharm. Bull. 34 1362 1365
33. K. Saito M. Nishijima N. Ohno T. Yadomae T. Miyazaki 1992 Structure and antitumor activity of the less-branched derivatives of an alkali-soluble glucan isolated from Omphalia lapidescens. (Studies on fungal polysaccharide. XXXVIII) Chem. Pharm. Bull. 40 261 263